JP2023540355A - 神経障害性疼痛の局所治療において使用するメピラミン - Google Patents

神経障害性疼痛の局所治療において使用するメピラミン Download PDF

Info

Publication number
JP2023540355A
JP2023540355A JP2023515153A JP2023515153A JP2023540355A JP 2023540355 A JP2023540355 A JP 2023540355A JP 2023515153 A JP2023515153 A JP 2023515153A JP 2023515153 A JP2023515153 A JP 2023515153A JP 2023540355 A JP2023540355 A JP 2023540355A
Authority
JP
Japan
Prior art keywords
weight
neuropathy
mepyramine
neuropathic pain
topical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023515153A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540355A5 (cg-RX-API-DMAC7.html
Inventor
セリーヌ グレコ
パトリック デルマス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Original Assignee
Centre National de la Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique filed Critical Centre National de la Recherche Scientifique
Publication of JP2023540355A publication Critical patent/JP2023540355A/ja
Publication of JP2023540355A5 publication Critical patent/JP2023540355A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023515153A 2020-09-11 2021-09-10 神経障害性疼痛の局所治療において使用するメピラミン Pending JP2023540355A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306009.0 2020-09-11
EP20306009.0A EP3967308A1 (en) 2020-09-11 2020-09-11 Mepyramine for use in the topical treatment of neuropathic pain
PCT/EP2021/074906 WO2022053598A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Publications (2)

Publication Number Publication Date
JP2023540355A true JP2023540355A (ja) 2023-09-22
JP2023540355A5 JP2023540355A5 (cg-RX-API-DMAC7.html) 2024-09-03

Family

ID=72615785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515153A Pending JP2023540355A (ja) 2020-09-11 2021-09-10 神経障害性疼痛の局所治療において使用するメピラミン

Country Status (7)

Country Link
US (1) US20230321059A1 (cg-RX-API-DMAC7.html)
EP (2) EP3967308A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023540355A (cg-RX-API-DMAC7.html)
KR (1) KR20230083272A (cg-RX-API-DMAC7.html)
AU (1) AU2021342331A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191653A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022053598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026119772A1 (fr) 2024-12-02 2026-06-11 Assistance Publique Hopitaux De Paris Nanoparticules de mepyramine et de squalene

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531298A (ja) * 2007-06-12 2010-09-24 エックスバシブ, インコーポレイテッド 疼痛を治療するための局所用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521342D0 (en) * 1985-08-27 1985-10-02 Univ Glasgow Medicament
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010531298A (ja) * 2007-06-12 2010-09-24 エックスバシブ, インコーポレイテッド 疼痛を治療するための局所用組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOMEDICAL RESEARCH, vol. 32, no. 3, JPN6025024415, 2011, pages 195 - 201, ISSN: 0005753873 *
EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 522, JPN6025024417, 2005, pages 55 - 62, ISSN: 0005753871 *
NEUROSCIENCE, vol. 109, no. 4, JPN6025024416, 2002, pages 811 - 818, ISSN: 0005753872 *

Also Published As

Publication number Publication date
US20230321059A1 (en) 2023-10-12
WO2022053598A1 (en) 2022-03-17
EP3967308A1 (en) 2022-03-16
CA3191653A1 (en) 2022-03-17
KR20230083272A (ko) 2023-06-09
EP4210699A1 (en) 2023-07-19
AU2021342331A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
US7084116B2 (en) Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators
JP6891385B2 (ja) トラジピタントによる治療方法
US20080146672A1 (en) Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue
EP3551166B1 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
JPH05504546A (ja) 痛みのある疾患又はアレルギー性疾患の治療用組成物及び治療法
JP2003533475A (ja) ニコチン性アセチルコリン受容体アゴニストによる、膣乾燥の治療方法
DE60315258T2 (de) Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
JP2017519034A (ja) 手足症候群及び前記症候群に随伴する症候を治療する方法
US7223754B2 (en) Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
MX2007003948A (es) Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20230321059A1 (en) Mepyramine for use in the topical treatment of neuropathic pain
CN113347975B (zh) 用于治疗侵蚀性手骨关节炎的孟鲁司特
Dietrich et al. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes
WO2004082686A2 (en) Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
US6214849B1 (en) Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans
KR20000029647A (ko) 양극성장애의치료방법
US20080255238A1 (en) Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
Yadav et al. Concise review: Therapeutic potential of flupirtine maleate
WO2026092738A1 (zh) 一种递送药物的方法及组合物
Bali et al. Drugs prescribed in prosthodontics: An overview
HK40119620A (en) Formulation for soft anticholinergic analogs
HK40119619A (en) Formulation for soft anticholinergic analogs
HK40119997A (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230406

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20230406

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240826

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240826

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250617

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250618

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251216